Patent · US Active

Role of miRNA in T cell leukemia

US8247388B2 · kind B2 · utility

1Cited by

0References

7Claims

0Family size

Assignee

The Board of Trustees of the Leland Stanford Junior University · US

Inventors

Chang-Zheng Chen · Stanford, US
Tin Mao · San Bruno, US

Key dates

Filing date	Jun 8, 2009
Grant date	Aug 21, 2012
Priority date	—
Expiry date	Jul 18, 2029

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12Q2600/178
WIPO fieldBiotechnology
WIPO sectorChemistry

Abstract

The ability of miR-181a to support active signaling between Notch and pre-TCR pathways by coordinately dampening negative regulators of these pathways allows the use of miR-181a as a therapeutic target for T-ALL.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.